KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Gsk (GSK) over the last 17 years, with Q4 2025 value amounting to -$859.2 million.

  • Gsk's Dividends Paid - Common rose 4512.95% to -$859.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.4 billion, marking a year-over-year decrease of 3365.38%. This contributed to the annual value of -$3.4 billion for FY2025, which is 823.03% down from last year.
  • Latest data reveals that Gsk reported Dividends Paid - Common of -$859.2 million as of Q4 2025, which was up 4512.95% from -$876.9 million recorded in Q3 2025.
  • Gsk's 5-year Dividends Paid - Common high stood at -$72.2 million for Q3 2023, and its period low was -$2.5 billion during Q4 2022.
  • Moreover, its 5-year median value for Dividends Paid - Common was -$745.7 million (2025), whereas its average is -$778.5 million.
  • As far as peak fluctuations go, Gsk's Dividends Paid - Common tumbled by 113990.92% in 2022, and later soared by 8822.36% in 2023.
  • Quarter analysis of 5 years shows Gsk's Dividends Paid - Common stood at -$322.2 million in 2021, then plummeted by 667.45% to -$2.5 billion in 2022, then skyrocketed by 44.18% to -$1.4 billion in 2023, then decreased by 13.46% to -$1.6 billion in 2024, then skyrocketed by 45.13% to -$859.2 million in 2025.
  • Its Dividends Paid - Common was -$859.2 million in Q4 2025, compared to -$876.9 million in Q3 2025 and -$875.1 million in Q2 2025.